Phase 1 trial of venetoclax with cladribine, cytarabine, G-CSF, and mitoxantrone for AML and high-grade myeloid neoplasm. - Raychaudhuri S; Gooley TA; Rasmussen A; Quach K; Gill E; Halpern AB; Appelbaum JS; Ghiuzeli CM; Hendrie PC; Cassaday RD; Walter RB; Percival MM (Blood neoplasia, 2025)